Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Congenital CMV Infection
NCT01037712Phase 4Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of valaciclovir in congenital cytomegalovirus infection (cCMV), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2009; status: terminated.
02
Drugs
valaciclovir
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on NCT01037712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037712.